Home › Osteoarthritis › Alabama › Birmingham
Osteoarthritis clinical trials in Birmingham, AL
4 studies for Osteoarthritis are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
RecruitingPhase 3
- Flourish Research Birmingham, Birmingham
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
RecruitingPhase 3
- Central Alabama Research, Birmingham
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)
RecruitingPhase 3
- Central Research Associates, LLC dba Flourish Research, Birmingham
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
RecruitingPhase 2
- Flourish Research - Birmingham, Birmingham
About Osteoarthritis
Osteoarthritis is the most common form of arthritis. It usually affects your hands, knees, hips, or spine. Learn about treatment and management.
More about Osteoarthritis on MedlinePlus
Osteoarthritis trials in other cities
- New York City, NY9 studies
- Chicago, IL8 studies
- Salt Lake City, UT5 studies
- Philadelphia, PA5 studies
- Charlotte, NC5 studies
- Tampa, FL5 studies
- Orlando, FL4 studies
- El Cajon, CA4 studies
- New Orleans, LA4 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- Gainesville, FL4 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Cardiovascular Disease16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.